Generation and characterization of PBMCs-derived human induced pluripotent stem cell (iPSC) line SDQLCHi050-A from a...

Area of Science:

• Stem cell biology
• Regenerative medicine
• Genetics

Background:

• Induced pluripotent stem cells (iPSCs) offer a powerful tool for disease modeling and therapeutic development.
• Deriving patient-specific iPSC lines is crucial for personalized medicine approaches.
• Human iPSC lines are essential for studying human development and disease in vitro.

Observation:

• A novel human induced pluripotent stem cell (iPSC) line, designated SDQLCHi050-A, was successfully generated.
• The iPSC line was derived from peripheral blood mononuclear cells (PBMCs) of a healthy 5-year-old male donor.
• Standard characterization methods were employed to assess the quality of the iPSC line.

Findings:

• Karyotyping analysis confirmed the genetic stability of the SDQLCHi050-A iPSC line.
• Pluripotency assays demonstrated the cells' ability to self-renew and maintain an undifferentiated state.
• Trilineage differentiation assays confirmed the capacity of SDQLCHi050-A cells to differentiate into ectoderm, mesoderm, and endoderm lineages.

Implications:

• The SDQLCHi050-A iPSC line provides a valuable resource for research in developmental biology and disease modeling.
• This well-characterized human iPSC line can be utilized in drug screening and regenerative medicine applications.
• Availability of this specific iPSC line facilitates further investigation into pediatric cell biology and potential therapeutic strategies.